Finerenone has been shown to significantly reduce the risk for cardiovascular death in patients with heart failure in results from the FINEARTS-HF trial.
The medication, finerenone, could be an effective therapy in people with heartfailure who have mildly reduced or preservedejectionfraction, suggests the study, published Sunday in the New ...